BMS-663068

BMS-626529 · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BMS-663068, covering 2017-05-15 to 2020-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 [Phase 2]